top of page
it's where dermatology lives


ARC-ZOR_NL_200409_OneBrand_MEDIA_Wban_EN_1260x126


ARC-ZOR_NL_200409_OneBrand_MEDIA_Wban_EN_1260x126
1/2


New approach to treating finger ulcers, gangrene
Botulinum toxin may offer a practical new option for patients with painful, treatment‑resistant ischemic lesions of the fingers, according to a systematic review and individual‑patient meta‑analysis published in JAMA Dermatology by investigators at the McGill University Health Centre (MUHC) in Montreal. Researchers at the Research Institute of the MUHC report that injections of botulinum toxin were associated with complete healing of digital lesions in more than 85% of 119 p
Allan Ryan
40 minutes ago2 min read


VIDEO: Study shows no link between AD and early cardiovascular risk in children, adolescents
There are no associations between AD and cardiovascular risk factors in children and adolescents.
Jeremy Visser
6 days ago1 min read


Surgical stitches with anti-inflammatory medications?
Photo by Benis Arapovic via Vecteezy Researchers in Arkansas are developing experimental surgical sutures that slowly release anti-inflammatory drugs at the wound site, aiming to curb local inflammation, reduce scarring, and potentially improve outcomes of delicate procedures. Working in the laboratory of chemist Sharon K. Hamilton, PhD, at Ouachita Baptist University, undergraduate researcher Mieya Kirby has focused on electrospun polymers, which can be drawn under high volt
Allan Ryan
Mar 302 min read


Avapritinib improves indolent systemic mastocytosis lesions, reduces symptoms
Mastocytosis. Photo by Doc James via Wikimedia Commons Recent findings show treatment with the selective KIT D816V inhibitor avapritinib for indolent systemic mastocytosis (ISM) improved dermatologic symptoms, decreased skin lesion size, normalized skin lesion colour, and reduced skin mast cell burden. The study was published in the Journal of the American Academy of Dermatology . In a press release , the study’s senior author, Karin Hartmann, MD, said that her mastocytosis p
John Evans
Mar 272 min read


VIDEO: Real world study shows upadacitinib effective in AD, HS
Upadacitinib was significantly effective in treating AD and modestly effective in treating HS
Jeremy Visser
Mar 251 min read


Key “lipid transporter” for skin barrier integrity identified
MFSD2A is required for the uptake of LPCs containing linoleic acid (LPC18:2) from the blood for normal development of the epidermis. The absence of MFSD2A leads to increased skin inflammation and thickening of the epidermis. Photo by: Bernice Wong Researchers at Duke-NUS Medical School in Singapore have pinpointed a lipid transporter that enables epidermal cells to import key fatty acids from the bloodstream, a mechanism they say is critical for preserving skin barrier integr
Allan Ryan
Mar 232 min read
Featured Posts


bottom of page
